Bifogade filer
Lipum AB - Report from the Extraordinary General Meeting
Prenumeration
Beskrivning
| Land | Sverige |
|---|---|
| Lista | First North Stockholm |
| Sektor | Hälsovård |
| Industri | Läkemedel & Handel |
An Extraordinay General Meeting (the “EGM”) in Lipum AB (publ), corporate identity number 556813-5999 (“Lipum” or the “Company”), today resolved to amend the Company’s articles of association and to approve the Board of Directors’ resolution on a rights issue of up to 27,944,055 shares. The EGM further resolved to approve the master services agreement which the Company entered into with NorthX Biologics AB on 29 February 2024.
At the EGM held on 2 April 2024, the general meeting resolved, in accordance with the proposed resolutions, as follows:
Resolution on a) amendment of the articles of association and b) approval of the Board of Directors’ resolution on a rights issue
The EGM resolved, in accordance with the Board of Directors’ proposal, to
- amend 4‑5 §§ of the articles of association so that the share capital shall be not less than SEK 4,564,191.75 and not more than SEK 18,256,767.00 and that the number of shares shall be not less than 18,256,767 and not more than 73,027,068; and
- approve the Board of Directors’ resolution on 29 February 2024 on a rights issue of up to 27,944,055 shares at a subscription price of SEK 6.70 per share.
Resolution on approval of master services agreement with NorthX
The EGM further resolved, in accordance with the Board of Directors’ proposal, to approve the master services agreement entered into with NorthX Biologics AB on 29 February 2024.
The minutes of the EGM (in Swedish) will be available on Lipum’s website, www.lipum.se.